Crosslinked α,β-Polyasparthydrazide Micromatrices for Controlled Release of Anticancer Drugs
Source abstract
Abstract
The preparation of new hydrogels by the reaction of α,β- polyasparthydrazide and glutaraldehyde is reported. A different crosslinking degree was obtained by varying the ratio crosslinking agent/polymer which influenced the swelling behavior of the gel. 5-Fluorouracil, was incorporated into the matrices during the crosslinking reaction and in vitro release studies were performed in simulated gastric juice (pH 1.1) and pH 7.4 buffer solution. The hydrogels prepared were chemically stable in the dissolution media. The observed data show the potential application of these new matrices for peroral administration of anticancer agents.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Biopolymer Synthesis and Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Dipartimento di Chimica e Tecnologie Farmaceutiche, Università di Palermo, Via Archirafi 32-90123-Palermo (Italy)
References (24)
Show source-provided references
1. Giammona, G. · Boll. Chim. Farm. · 1989 · 128 · 62
2. 10.1016/0168-3659(94)90122-810.1016/0168-3659(94)90122-8 ↗
3. Peppas, N. A. · 1988
4. 10.1016/0168-3659(91)90046-G10.1016/0168-3659(91)90046-G ↗
5. 10.1016/0168-3659(92)90194-V10.1016/0168-3659(92)90194-V ↗
6. 6. Kudela, V. 1987. Hydrogels, in: Encyclopedia of Polymer Science and Engineering New York: Wiley, 7:783-807.
7. 10.1016/0142-9612(83)90025-X10.1016/0142-9612(83)90025-X ↗
8. 10.1016/0168-3659(90)90078-810.1016/0168-3659(90)90078-8 ↗
9. 10.1016/0168-3659(92)90200-B10.1016/0168-3659(92)90200-B ↗
10. 10.1023/A:101594933042510.1023/A:1015949330425 ↗
11. Korsmeyer, R. W. · 1983
12. 10.1016/S0376-7388(00)80265-310.1016/S0376-7388(00)80265-3 ↗
13. 10.1016/0168-3659(91)90042-C10.1016/0168-3659(91)90042-C ↗
14. 10.1016/0168-3659(91)90044-E10.1016/0168-3659(91)90044-E ↗
15. Schmahl, D. · Int. J. Exp Clin. Chemother · 1988 · 1 · 1
16. 10.1016/0168-3659(91)90034-B10.1016/0168-3659(91)90034-B ↗
17. 10.1016/0168-3659(91)90036-D10.1016/0168-3659(91)90036-D ↗
18. Bosch, L. · Cancer Rev. · 1958 · 18 · 335
19. Bounous, G. · Int. J. Chem. Pharmacol. Biopharm. · 1978 · 16 · 519
20. 20. Chabner, B. A. 1982. Pharmacologic Principles of Cancer Treatment, B. A. Chabner, ed. Philadelphia: Saunders, pp. 132-142.
21. 10.1016/0003-2697(90)90677-210.1016/0003-2697(90)90677-2 ↗
22. 10.1016/0378-4347(92)80125-A10.1016/0378-4347(92)80125-A ↗
23. 10.1016/0168-3659(92)90194-V10.1016/0168-3659(92)90194-V ↗
24. 10.1002/jps.260070022610.1002/jps.2600700226 ↗